{"organizations": [], "uuid": "c19196d6532facf304397286df65b828d73e9a81", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180214.html", "section_title": "Archive News &amp; Video for Wednesday, 14 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-meilleure-health-international-ind/brief-meilleure-health-international-industry-says-unit-to-buy-stake-in-yunnan-hansu-biotechnology-idUSFWN1Q412V", "country": "US", "domain_rank": 408, "title": "BRIEF-Meilleure Health International Industry Says Unit To Buy Stake In Yunnan Hansu Biotechnology", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.975, "site_type": "news", "published": "2018-02-14T21:32:00.000+02:00", "replies_count": 0, "uuid": "c19196d6532facf304397286df65b828d73e9a81"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-meilleure-health-international-ind/brief-meilleure-health-international-industry-says-unit-to-buy-stake-in-yunnan-hansu-biotechnology-idUSFWN1Q412V", "ord_in_thread": 0, "title": "BRIEF-Meilleure Health International Industry Says Unit To Buy Stake In Yunnan Hansu Biotechnology", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "wuhu meilleure", "sentiment": "negative"}, {"name": "brief-meilleure health international industry says unit to buy stake in yunnan hansu biotechnology", "sentiment": "negative"}, {"name": "reuters) - meilleure health international industry group ltd", "sentiment": "neutral"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 14 (Reuters) - Meilleure Health International Industry Group Ltd:\n* WUHU MEILLEURE TO BUY 20% EQUITY INTEREST OF YUNNAN HANSU BIOTECHNOLOGY FOR RMB60 MILLION FROM HEMP INVESTMENT\n* APPLICATION MADE TO STOCK EXCHANGE FOR RESUMPTION OF TRADING IN SHARES WITH EFFECT FROM 15 FEB Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-14T21:32:00.000+02:00", "crawled": "2018-02-15T20:59:34.010+02:00", "highlightTitle": ""}